Feline atopic skin syndrome (FASS) is a diagnosis of exclusion, requiring elimination of flea allergy, food allergy, external parasites, bacterial skin infection, and dermatophytosis before the diagnosis is confirmed. Up to 25–30% of FASS cats exhibit seasonal pruritus, which supports an environmental allergy diagnosis without requiring a dietary elimination trial, provided external parasites and secondary infections have been addressed.AAHA Clinical G… In the non-seasonal pruritic cat, failure to respond to a strict elimination diet trial is required to implicate FASS.AAHA Clinical G…
Once FASS is confirmed, intradermal or serum allergy testing by a veterinary dermatologist identifies specific environmental allergens for inclusion in allergen-specific immunotherapy (ASIT). Referral to a dermatologist at the point of confirmed diagnosis is recommended, as targeted treatment reduces the client frustration and loss of trust that accompanies empirical therapeutic trials.AAHA Clinical G… If referral is not possible, establishing a baseline pruritus score before initiating treatment allows objective assessment of therapeutic response.AAHA Clinical G…
Glucocorticoids are first-line for initial pruritus control and serve as a diagnostic test of therapeutic response, given that most allergic cats respond to them.AAHA Clinical G… When pruritus exceeds 6 out of 12 months per year, long-term alternatives should be discussed with the owner.AAHA Clinical G…
Cyclosporine is the only labeled systemic treatment for FASS in Canada and reaches therapeutic levels at 4–6 weeks, after which dosing frequency can often be reduced to every other day or less.AAHA Clinical G… Cyclosporine is contraindicated in outdoor cats due to the risk of fatal infectious disease exposure, particularly toxoplasmosis; cats on cyclosporine should be fed a cooked diet and maintained on effective internal and external parasite control.AAHA Clinical G… Systemic toxoplasmosis has been reported in cats receiving cyclosporine or prednisolone for FASS.Veterinary Derm…
Oclacitinib (Apoquel, Zoetis) is an off-label Janus kinase 1 inhibitor with demonstrated antipruritic and anti-inflammatory efficacy in FASS, but it is not registered for use in cats.Veterinary Derm… Its use in cats with concurrent retroviral infections such as feline immunodeficiency virus (FIV) should be approached with caution, as immunocompromise increases the risk of opportunistic infections including fatal disseminated toxoplasmosis.Veterinary Derm… Where no alternative exists in FIV-positive cats, prophylactic use of clindamycin, pyrimethamine, or trimethoprim-sulfamethoxazole should be considered to mitigate this risk.Veterinary Derm… Regardless of retroviral status, cats receiving oclacitinib should be fed only cooked commercial food, housed indoors to prevent hunting and scavenging, and monitored with haematology, serum biochemistry, and urinalysis for leucocyte changes and renal dysfunction.Veterinary Derm…
ASIT, including rush immunotherapy (RIT), is a viable long-term option once offending allergens are identified. In RIT, allergen extracts are administered subcutaneously at increasing concentrations every 30 minutes until a maintenance dose of 20,000 protein nitrogen units/mL is reached, with cats premedicated with an antihistamine and hospitalized for observation.Journal of Feli… Both cats in the published case series completed RIT without adverse reactions and showed clinical improvement.Journal of Feli…
Topical management and dietary adjuncts provide additional benefit in multimodal protocols. Topical glucocorticoids are the only topical option with reported efficacy in feline atopy.Journal of Feli… A novel dietary formulation tested over 6 months improved owner-assessed pruritus scores at 3 months and significantly reduced medication requirements compared to a control diet.Animals An adsorbent mousse containing adelmidrol, tapioca starch, and a non-pharmacological antimicrobial complex significantly reduced seborrhoea, pruritus, and skin lesion scores at 2 weeks in FASS cats with concurrent seborrhoea.Veterinary Derm…
Other suggested therapies — including oclacitinib (in non-immunocompromised cats), maropitant, essential fatty acids, and oral H1-receptor blocking antihistamines — have limited evidence of efficacy in FASS cats.Veterinary Derm…
| Treatment | Protocol | Efficacy | Key Caveat |
|---|---|---|---|
| Glucocorticoids (prednisolone) | Standard anti-inflammatory dosing | First-line; most allergic cats respond | Long-term use associated with adverse effects; toxoplasmosis risk reportedAAHA Clinical G…+1 |
| Cyclosporine | Labeled; reduce to every-other-day after 4–6 wk | Labeled treatment; good evidenceAAHA Clinical G…+1 | Contraindicated in outdoor cats; cooked diet required; toxoplasmosis riskAAHA Clinical G…+1 |
| Oclacitinib | Off-label in cats | Effective antipruritic and anti-inflammatoryVeterinary Derm… | Not registered for cats; avoid in FIV-positive cats; consider prophylactic antimicrobials if no alternativeVeterinary Derm… |
| ASIT / Rush immunotherapy | Subcutaneous; maintenance 20,000 PNU/mL; premedicate with antihistamineJournal of Feli… | Clinical improvement in published cases; long-term disease modificationAAHA Clinical G…+1 | Requires allergen identification by dermatologist; limited feline dataJournal of Feli… |
| Dietary adjunct | Novel formulation over 6 monthsAnimals | Improved pruritus scores at 3 months; reduced medication requirementsAnimals | Adjunct only; not a standalone therapy |
| Topical adelmidrol mousse | Weekly application for 2–4 weeksVeterinary Derm… | Significant reduction in seborrhoea, pruritus, and skin lesion scores at 2 weeksVeterinary Derm… | Pilot data only; best studied in FASS with concurrent seborrhoea |
Would you like guidance on cyclosporine monitoring protocols and how to manage cats that fail to respond after the 4–6 week induction period?